

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.65171277 |
| 2 | DNA unwinding involved in DNA replication (GO:0006268) | 4.44976858 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.15864211 |
| 4 | protein localization to kinetochore (GO:0034501) | 3.97329677 |
| 5 | mitotic chromosome condensation (GO:0007076) | 3.92625725 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 3.83203594 |
| 7 | germinal center formation (GO:0002467) | 3.82841047 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81530998 |
| 9 | negative regulation of cell killing (GO:0031342) | 3.81530998 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72169610 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71992058 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65382416 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65382416 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.65382416 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65382416 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.65382416 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65382416 |
| 18 | positive thymic T cell selection (GO:0045059) | 3.56838761 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51927166 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.51927166 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49867130 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 3.44578132 |
| 23 | regulation of translational fidelity (GO:0006450) | 3.44114793 |
| 24 | valine metabolic process (GO:0006573) | 3.44044937 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.43530018 |
| 26 | response to interleukin-15 (GO:0070672) | 3.43095738 |
| 27 | negative T cell selection (GO:0043383) | 3.42877611 |
| 28 | response to peptidoglycan (GO:0032494) | 3.41092592 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.34876672 |
| 30 | detection of other organism (GO:0098543) | 3.27112223 |
| 31 | sister chromatid segregation (GO:0000819) | 3.26266129 |
| 32 | nuclear pore complex assembly (GO:0051292) | 3.23604877 |
| 33 | heterochromatin organization (GO:0070828) | 3.23360003 |
| 34 | DNA duplex unwinding (GO:0032508) | 3.20729345 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19529178 |
| 36 | mitotic sister chromatid segregation (GO:0000070) | 3.19019541 |
| 37 | dosage compensation (GO:0007549) | 3.18866706 |
| 38 | glycine metabolic process (GO:0006544) | 3.18440624 |
| 39 | mitotic nuclear envelope disassembly (GO:0007077) | 3.18353928 |
| 40 | nuclear pore organization (GO:0006999) | 3.18091875 |
| 41 | protein localization to chromosome, centromeric region (GO:0071459) | 3.17942888 |
| 42 | DNA geometric change (GO:0032392) | 3.17599089 |
| 43 | sulfur amino acid catabolic process (GO:0000098) | 3.17284691 |
| 44 | mitotic sister chromatid cohesion (GO:0007064) | 3.17115763 |
| 45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15174226 |
| 46 | positive T cell selection (GO:0043368) | 3.14537307 |
| 47 | negative regulation of histone methylation (GO:0031061) | 3.13869653 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12619121 |
| 49 | cellular response to growth hormone stimulus (GO:0071378) | 3.10980278 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.10022372 |
| 51 | tetrahydrofolate metabolic process (GO:0046653) | 3.09061143 |
| 52 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07836535 |
| 53 | detection of bacterium (GO:0016045) | 3.07388472 |
| 54 | one-carbon metabolic process (GO:0006730) | 3.06384692 |
| 55 | thymic T cell selection (GO:0045061) | 3.06036200 |
| 56 | V(D)J recombination (GO:0033151) | 3.01644602 |
| 57 | regulation of B cell differentiation (GO:0045577) | 3.01434386 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.00400943 |
| 59 | membrane disassembly (GO:0030397) | 2.99644907 |
| 60 | nuclear envelope disassembly (GO:0051081) | 2.99644907 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.98676664 |
| 62 | T cell selection (GO:0045058) | 2.96491011 |
| 63 | cellular hyperosmotic response (GO:0071474) | 2.95379093 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.94620305 |
| 65 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.93603300 |
| 66 | UMP biosynthetic process (GO:0006222) | 2.93603300 |
| 67 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.93603300 |
| 68 | UMP metabolic process (GO:0046049) | 2.93603300 |
| 69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.91340384 |
| 70 | IMP biosynthetic process (GO:0006188) | 2.91336801 |
| 71 | histone H2A monoubiquitination (GO:0035518) | 2.90857836 |
| 72 | low-density lipoprotein particle clearance (GO:0034383) | 2.90111350 |
| 73 | urea cycle (GO:0000050) | 2.89548172 |
| 74 | urea metabolic process (GO:0019627) | 2.89548172 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.88445172 |
| 76 | Peyers patch development (GO:0048541) | 2.88445172 |
| 77 | cellular extravasation (GO:0045123) | 2.87624629 |
| 78 | lysine catabolic process (GO:0006554) | 2.85149457 |
| 79 | lysine metabolic process (GO:0006553) | 2.85149457 |
| 80 | detection of biotic stimulus (GO:0009595) | 2.84403186 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 2.84394191 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 2.84169497 |
| 83 | pentose-phosphate shunt (GO:0006098) | 2.84118756 |
| 84 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.83007111 |
| 85 | regulation of translational termination (GO:0006449) | 2.80726449 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80203572 |
| 87 | growth hormone receptor signaling pathway (GO:0060396) | 2.78424546 |
| 88 | regulation of histone H3-K9 methylation (GO:0051570) | 2.78053303 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77597070 |
| 90 | DNA replication initiation (GO:0006270) | 2.76895434 |
| 91 | IMP metabolic process (GO:0046040) | 2.76558060 |
| 92 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75485759 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75465194 |
| 94 | tolerance induction (GO:0002507) | 2.73652401 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.73622558 |
| 96 | response to host immune response (GO:0052572) | 2.73622558 |
| 97 | tricarboxylic acid metabolic process (GO:0072350) | 2.72977392 |
| 98 | NADPH regeneration (GO:0006740) | 2.72854982 |
| 99 | regulation of necroptotic process (GO:0060544) | 2.72587040 |
| 100 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.72251798 |
| 101 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.70969855 |
| 102 | chromatin assembly (GO:0031497) | 2.70121529 |
| 103 | positive regulation of chromosome segregation (GO:0051984) | 2.70099852 |
| 104 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69700521 |
| 105 | peptidyl-lysine dimethylation (GO:0018027) | 2.69600567 |
| 106 | regulation of sister chromatid cohesion (GO:0007063) | 2.69587254 |
| 107 | creatine metabolic process (GO:0006600) | 2.68827300 |
| 108 | positive regulation of tolerance induction (GO:0002645) | 2.67948535 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64514362 |
| 110 | cellular response to interleukin-15 (GO:0071350) | 2.63988000 |
| 111 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63979637 |
| 112 | maternal placenta development (GO:0001893) | 2.63452291 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.63379722 |
| 114 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.62656867 |
| 115 | L-phenylalanine metabolic process (GO:0006558) | 2.62656867 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.61905023 |
| 117 | cysteine metabolic process (GO:0006534) | 2.60899670 |
| 118 | serine family amino acid catabolic process (GO:0009071) | 2.60470539 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60335394 |
| 120 | response to host (GO:0075136) | 2.60335394 |
| 121 | response to host defenses (GO:0052200) | 2.60335394 |
| 122 | mRNA stabilization (GO:0048255) | 2.60103550 |
| 123 | RNA stabilization (GO:0043489) | 2.60103550 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.58957725 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.58686692 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58137074 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58003117 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 2.57845759 |
| 129 | glyoxylate metabolic process (GO:0046487) | 2.57815264 |
| 130 | COPI coating of Golgi vesicle (GO:0048205) | 2.57521393 |
| 131 | Golgi transport vesicle coating (GO:0048200) | 2.57521393 |
| 132 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.57104154 |
| 133 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.56815324 |
| 134 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.56449733 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56057773 |
| 136 | DNA strand elongation (GO:0022616) | 2.55674366 |
| 137 | nuclear envelope organization (GO:0006998) | 2.55608528 |
| 138 | B cell receptor signaling pathway (GO:0050853) | 2.55312039 |
| 139 | folic acid metabolic process (GO:0046655) | 2.54999479 |
| 140 | response to type I interferon (GO:0034340) | 2.54613860 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.54190696 |
| 142 | cellular response to type I interferon (GO:0071357) | 2.54013376 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.54013376 |
| 144 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.53820789 |
| 145 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.53820789 |
| 146 | nitrogen cycle metabolic process (GO:0071941) | 2.53278718 |
| 147 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52981588 |
| 148 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52981588 |
| 149 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.52602462 |
| 150 | negative regulation of T cell apoptotic process (GO:0070233) | 2.52452685 |
| 151 | folic acid-containing compound metabolic process (GO:0006760) | 2.52168890 |
| 152 | DNA conformation change (GO:0071103) | 2.49737366 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.49723620 |
| 154 | L-phenylalanine catabolic process (GO:0006559) | 2.49723620 |
| 155 | regulation of T cell tolerance induction (GO:0002664) | 2.48993574 |
| 156 | regulation of cholesterol homeostasis (GO:2000188) | 2.48619621 |
| 157 | protein localization to chromosome (GO:0034502) | 2.47974528 |
| 158 | definitive hemopoiesis (GO:0060216) | 2.46405797 |
| 159 | nucleobase biosynthetic process (GO:0046112) | 2.46251446 |
| 160 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45952763 |
| 161 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.44479085 |
| 162 | L-serine metabolic process (GO:0006563) | 2.44043999 |
| 163 | leukocyte aggregation (GO:0070486) | 2.44015285 |
| 164 | kynurenine metabolic process (GO:0070189) | 2.43424642 |
| 165 | gene silencing by RNA (GO:0031047) | 2.41340115 |
| 166 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40970330 |
| 167 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.40940374 |
| 168 | B cell mediated immunity (GO:0019724) | 2.40477585 |
| 169 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.40340496 |
| 170 | pore complex assembly (GO:0046931) | 2.40295113 |
| 171 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39941689 |
| 172 | nucleotide salvage (GO:0043173) | 2.39305861 |
| 173 | megakaryocyte development (GO:0035855) | 2.39139088 |
| 174 | negative regulation of innate immune response (GO:0045824) | 2.38213323 |
| 175 | cellular response to epinephrine stimulus (GO:0071872) | 2.38039239 |
| 176 | negative regulation of type 2 immune response (GO:0002829) | 2.37902316 |
| 177 | oxaloacetate metabolic process (GO:0006107) | 2.37537967 |
| 178 | mitotic metaphase plate congression (GO:0007080) | 2.37210403 |
| 179 | pre-miRNA processing (GO:0031054) | 2.37155704 |
| 180 | chromosome condensation (GO:0030261) | 2.37148461 |
| 181 | pyrimidine nucleoside salvage (GO:0043097) | 2.36626649 |
| 182 | regulation of macrophage cytokine production (GO:0010935) | 2.36038653 |
| 183 | regulation of regulatory T cell differentiation (GO:0045589) | 2.35737453 |
| 184 | complement activation, alternative pathway (GO:0006957) | 2.35400346 |
| 185 | regulation of hypersensitivity (GO:0002883) | 2.33304194 |
| 186 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.31535141 |
| 187 | regulation of granulocyte differentiation (GO:0030852) | 2.31201246 |
| 188 | neutrophil activation (GO:0042119) | 2.31149889 |
| 189 | positive regulation of interferon-alpha production (GO:0032727) | 2.30268972 |
| 190 | macrophage activation (GO:0042116) | 2.30079563 |
| 191 | carnitine shuttle (GO:0006853) | 2.29480379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.50936176 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81986282 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63703919 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.48916268 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00545382 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.35289456 |
| 7 | * MYC_22102868_ChIP-Seq_BL_Human | 3.06165008 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73624012 |
| 9 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70019535 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.58057264 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.56766856 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54506634 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54151310 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53303760 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.50142305 |
| 16 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45371116 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44828707 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36727884 |
| 19 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36121896 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.35185260 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.33825593 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22847878 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.19406011 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08676954 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01188824 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97388912 |
| 27 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.95821908 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94964934 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92821679 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88476652 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88065976 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85825021 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81360448 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79888726 |
| 35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79621432 |
| 36 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79479366 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77526511 |
| 38 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.71100295 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.68339992 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64335908 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61086520 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.60634531 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54397716 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51208319 |
| 45 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.50027294 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48914424 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47352666 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.45740120 |
| 49 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45711013 |
| 50 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.45189526 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42713078 |
| 52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.41398120 |
| 53 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.40857117 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40129364 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40109045 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.39674458 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37580974 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37394648 |
| 59 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36419829 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.35564120 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34521147 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32695672 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32284558 |
| 64 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32039709 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31684489 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31608373 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31282506 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31090362 |
| 69 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.30768797 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30668370 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.29297158 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28064619 |
| 73 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26076035 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25911736 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23237398 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22492388 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22013415 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21993540 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21828488 |
| 80 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.21145756 |
| 81 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20921011 |
| 82 | * MYB_26560356_Chip-Seq_TH2_Human | 1.20734699 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20614489 |
| 84 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20491512 |
| 85 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20491512 |
| 86 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.20077471 |
| 87 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19010739 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18113247 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17672641 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17409403 |
| 91 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16709525 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.16277687 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16163228 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16050324 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16014213 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15361274 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12853822 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12400465 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10673240 |
| 100 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10652210 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10407980 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10314161 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05080919 |
| 104 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04120914 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03977456 |
| 106 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.03614623 |
| 107 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03257406 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03086460 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02432663 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00823468 |
| 111 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00025506 |
| 112 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99673644 |
| 113 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99405182 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98606255 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97886976 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97504236 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96668711 |
| 118 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95447115 |
| 119 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.93210882 |
| 120 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92946063 |
| 121 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92780073 |
| 122 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92764966 |
| 123 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92642303 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92355144 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92328822 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92166248 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91912016 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91442469 |
| 129 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90444502 |
| 130 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90218306 |
| 131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90181114 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89983274 |
| 133 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89012862 |
| 134 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87852991 |
| 135 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86334643 |
| 136 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86140277 |
| 137 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84657712 |
| 138 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84651113 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84294671 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.83933194 |
| 141 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83913948 |
| 142 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.83912738 |
| 143 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83344647 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83324248 |
| 145 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83280272 |
| 146 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82694773 |
| 147 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.82482350 |
| 148 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.82482350 |
| 149 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.82482350 |
| 150 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81609755 |
| 151 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81221434 |
| 152 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80876329 |
| 153 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80344037 |
| 154 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.79900469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.72819911 |
| 2 | MP0005360_urolithiasis | 3.07383536 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.01471311 |
| 4 | MP0003436_decreased_susceptibility_to | 2.85685250 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.77517529 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.58508974 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.57986954 |
| 8 | MP0005365_abnormal_bile_salt | 2.56940483 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.51939408 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.50028240 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.28206217 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.21073507 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.21047730 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.18868109 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.12553183 |
| 16 | MP0003828_pulmonary_edema | 2.08475700 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.07318269 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.06229952 |
| 19 | MP0001800_abnormal_humoral_immune | 2.02595189 |
| 20 | MP0005076_abnormal_cell_differentiation | 1.99868201 |
| 21 | MP0002419_abnormal_innate_immunity | 1.95486158 |
| 22 | MP0003077_abnormal_cell_cycle | 1.93010194 |
| 23 | MP0005671_abnormal_response_to | 1.92826533 |
| 24 | MP0008004_abnormal_stomach_pH | 1.89134725 |
| 25 | MP0001790_abnormal_immune_system | 1.87164743 |
| 26 | MP0005387_immune_system_phenotype | 1.87164743 |
| 27 | MP0009278_abnormal_bone_marrow | 1.86077542 |
| 28 | MP0005025_abnormal_response_to | 1.85393179 |
| 29 | MP0009785_altered_susceptibility_to | 1.83426715 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.82517931 |
| 31 | MP0001661_extended_life_span | 1.78983562 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.78878234 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.78456074 |
| 34 | MP0009840_abnormal_foam_cell | 1.77826465 |
| 35 | MP0002723_abnormal_immune_serum | 1.76155989 |
| 36 | MP0010307_abnormal_tumor_latency | 1.75731205 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.74696329 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.71962649 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.71545281 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.71175497 |
| 41 | MP0001730_embryonic_growth_arrest | 1.69980581 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.67413427 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.66943761 |
| 44 | MP0003252_abnormal_bile_duct | 1.65452221 |
| 45 | MP0001819_abnormal_immune_cell | 1.64966261 |
| 46 | MP0005666_abnormal_adipose_tissue | 1.59080025 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.58784696 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.57957795 |
| 49 | MP0000609_abnormal_liver_physiology | 1.57424392 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.57222134 |
| 51 | MP0001853_heart_inflammation | 1.56967946 |
| 52 | MP0002009_preneoplasia | 1.56931198 |
| 53 | MP0008057_abnormal_DNA_replication | 1.56283158 |
| 54 | MP0003646_muscle_fatigue | 1.56106676 |
| 55 | MP0005670_abnormal_white_adipose | 1.54517566 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.48880959 |
| 57 | MP0001849_ear_inflammation | 1.45258325 |
| 58 | MP0002405_respiratory_system_inflammati | 1.43991556 |
| 59 | MP0000350_abnormal_cell_proliferation | 1.40548345 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.39415198 |
| 61 | MP0001851_eye_inflammation | 1.39137729 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.36114458 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.36114458 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.34621800 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.31342558 |
| 66 | MP0004233_abnormal_muscle_weight | 1.30261017 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.29391565 |
| 68 | MP0000490_abnormal_crypts_of | 1.27948499 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.27534271 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.27199449 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.26720436 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.25904613 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.24214810 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.23498262 |
| 75 | MP0004510_myositis | 1.22410553 |
| 76 | MP0001672_abnormal_embryogenesis/_devel | 1.20957836 |
| 77 | MP0005380_embryogenesis_phenotype | 1.20957836 |
| 78 | MP0008469_abnormal_protein_level | 1.20781993 |
| 79 | MP0003011_delayed_dark_adaptation | 1.18989994 |
| 80 | MP0005023_abnormal_wound_healing | 1.17887844 |
| 81 | MP0003075_altered_response_to | 1.16286844 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 1.16174113 |
| 83 | MP0003984_embryonic_growth_retardation | 1.15799734 |
| 84 | MP0005334_abnormal_fat_pad | 1.14812758 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 1.12876471 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.12694388 |
| 87 | MP0005647_abnormal_sex_gland | 1.11965809 |
| 88 | MP0008007_abnormal_cellular_replicative | 1.11750203 |
| 89 | MP0004947_skin_inflammation | 1.11282561 |
| 90 | MP0001697_abnormal_embryo_size | 1.09609629 |
| 91 | MP0009643_abnormal_urine_homeostasis | 1.09395995 |
| 92 | MP0001873_stomach_inflammation | 1.09376187 |
| 93 | MP0004883_abnormal_blood_vessel | 1.07683473 |
| 94 | MP0005332_abnormal_amino_acid | 1.07433351 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 1.06854307 |
| 96 | MP0000598_abnormal_liver_morphology | 1.06216735 |
| 97 | MP0002080_prenatal_lethality | 1.05511264 |
| 98 | MP0002722_abnormal_immune_system | 1.05299254 |
| 99 | MP0001666_abnormal_nutrient_absorption | 1.04780210 |
| 100 | MP0000751_myopathy | 1.04448540 |
| 101 | MP0002084_abnormal_developmental_patter | 1.03391450 |
| 102 | MP0005330_cardiomyopathy | 1.01626362 |
| 103 | MP0009672_abnormal_birth_weight | 1.00729133 |
| 104 | MP0005451_abnormal_body_composition | 1.00355217 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.99936815 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.99527931 |
| 107 | MP0002398_abnormal_bone_marrow | 0.99460759 |
| 108 | MP0009763_increased_sensitivity_to | 0.99456362 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.98799382 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.98763036 |
| 111 | MP0009764_decreased_sensitivity_to | 0.98273312 |
| 112 | MP0002006_tumorigenesis | 0.97397971 |
| 113 | MP0005164_abnormal_response_to | 0.97139384 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.95653564 |
| 115 | MP0002970_abnormal_white_adipose | 0.95171418 |
| 116 | MP0004130_abnormal_muscle_cell | 0.94656505 |
| 117 | MP0002085_abnormal_embryonic_tissue | 0.93999066 |
| 118 | MP0006138_congestive_heart_failure | 0.92125746 |
| 119 | MP0000689_abnormal_spleen_morphology | 0.91856477 |
| 120 | MP0003045_fibrosis | 0.91583293 |
| 121 | MP0001915_intracranial_hemorrhage | 0.90601360 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.89606125 |
| 123 | MP0000477_abnormal_intestine_morphology | 0.89555255 |
| 124 | MP0005310_abnormal_salivary_gland | 0.89542048 |
| 125 | MP0002933_joint_inflammation | 0.89260007 |
| 126 | MP0001919_abnormal_reproductive_system | 0.88234706 |
| 127 | MP0006082_CNS_inflammation | 0.88227034 |
| 128 | MP0002132_abnormal_respiratory_system | 0.87308979 |
| 129 | MP0000685_abnormal_immune_system | 0.86963267 |
| 130 | MP0000249_abnormal_blood_vessel | 0.84408176 |
| 131 | MP0000858_altered_metastatic_potential | 0.83722125 |
| 132 | MP0005535_abnormal_body_temperature | 0.82590294 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.82146147 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.81501848 |
| 135 | MP0002118_abnormal_lipid_homeostasis | 0.80750990 |
| 136 | MP0005166_decreased_susceptibility_to | 0.80513963 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.80146359 |
| 138 | MP0002106_abnormal_muscle_physiology | 0.79784164 |
| 139 | MP0003866_abnormal_defecation | 0.79603046 |
| 140 | MP0003303_peritoneal_inflammation | 0.79334060 |
| 141 | MP0003699_abnormal_female_reproductive | 0.78469453 |
| 142 | MP0008058_abnormal_DNA_repair | 0.76848000 |
| 143 | MP0004019_abnormal_vitamin_homeostasis | 0.76130748 |
| 144 | MP0002269_muscular_atrophy | 0.75888734 |
| 145 | MP0003453_abnormal_keratinocyte_physiol | 0.75552246 |
| 146 | MP0002138_abnormal_hepatobiliary_system | 0.74236073 |
| 147 | MP0000313_abnormal_cell_death | 0.73176715 |
| 148 | MP0002429_abnormal_blood_cell | 0.72169145 |
| 149 | MP0009115_abnormal_fat_cell | 0.70708380 |
| 150 | MP0000716_abnormal_immune_system | 0.69561246 |
| 151 | MP0008877_abnormal_DNA_methylation | 0.68512312 |
| 152 | MP0002971_abnormal_brown_adipose | 0.68010073 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.67246130 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.66754086 |
| 155 | MP0002796_impaired_skin_barrier | 0.65584935 |
| 156 | MP0006054_spinal_hemorrhage | 0.64954701 |
| 157 | MP0005408_hypopigmentation | 0.64740522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.05258386 |
| 2 | Nemaline bodies (HP:0003798) | 3.80264451 |
| 3 | Exercise-induced myalgia (HP:0003738) | 3.79481976 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 3.76777779 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.70597473 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.68188353 |
| 7 | Myositis (HP:0100614) | 3.66874119 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42087443 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33821213 |
| 10 | Orchitis (HP:0100796) | 3.29414128 |
| 11 | T lymphocytopenia (HP:0005403) | 3.27110675 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.19911538 |
| 13 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.11398498 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.10545809 |
| 15 | Ependymoma (HP:0002888) | 3.04693077 |
| 16 | Recurrent abscess formation (HP:0002722) | 2.98512806 |
| 17 | Abnormality of T cell number (HP:0011839) | 2.96534944 |
| 18 | Increased IgE level (HP:0003212) | 2.93112229 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.90836785 |
| 20 | Optic neuritis (HP:0100653) | 2.90836785 |
| 21 | Stomatitis (HP:0010280) | 2.87340928 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 2.83869347 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.82124455 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.79904269 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 2.78654731 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.74572602 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70040641 |
| 28 | Meningitis (HP:0001287) | 2.69784305 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.68381281 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.67626626 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.67000558 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.66038677 |
| 33 | Complement deficiency (HP:0004431) | 2.65781719 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65155034 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.63185154 |
| 36 | Spastic diplegia (HP:0001264) | 2.63091384 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.61103251 |
| 38 | Pseudobulbar signs (HP:0002200) | 2.59654324 |
| 39 | EMG: myopathic abnormalities (HP:0003458) | 2.59603280 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.56811545 |
| 41 | Increased connective tissue (HP:0009025) | 2.55505948 |
| 42 | Intrahepatic cholestasis (HP:0001406) | 2.53628459 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 2.53551279 |
| 44 | Myoglobinuria (HP:0002913) | 2.52821243 |
| 45 | Arterial thrombosis (HP:0004420) | 2.52650992 |
| 46 | Combined immunodeficiency (HP:0005387) | 2.52317313 |
| 47 | Subaortic stenosis (HP:0001682) | 2.49397872 |
| 48 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.49397872 |
| 49 | Xanthomatosis (HP:0000991) | 2.47686616 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45909697 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.45341644 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.43119107 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.42580105 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.41216554 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.40321625 |
| 56 | Epistaxis (HP:0000421) | 2.39703172 |
| 57 | Acute hepatic failure (HP:0006554) | 2.39037350 |
| 58 | Colitis (HP:0002583) | 2.37864567 |
| 59 | Hyperammonemia (HP:0001987) | 2.37483506 |
| 60 | Vasculitis (HP:0002633) | 2.36862955 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.36513339 |
| 62 | Chest pain (HP:0100749) | 2.35688216 |
| 63 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34007813 |
| 64 | Polycythemia (HP:0001901) | 2.33791095 |
| 65 | Cellulitis (HP:0100658) | 2.30626622 |
| 66 | Fatigue (HP:0012378) | 2.30483021 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.28550377 |
| 68 | Encephalitis (HP:0002383) | 2.28530509 |
| 69 | Enlarged penis (HP:0000040) | 2.26249831 |
| 70 | Gingival bleeding (HP:0000225) | 2.23815636 |
| 71 | Rhabdomyosarcoma (HP:0002859) | 2.23167842 |
| 72 | Rectal prolapse (HP:0002035) | 2.22175505 |
| 73 | Neck muscle weakness (HP:0000467) | 2.21773611 |
| 74 | Multiple enchondromatosis (HP:0005701) | 2.21740060 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.21005819 |
| 76 | B lymphocytopenia (HP:0010976) | 2.21005819 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20973100 |
| 78 | Abnormality of T cells (HP:0002843) | 2.20781134 |
| 79 | Osteomyelitis (HP:0002754) | 2.20667723 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.20107840 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.19608357 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18378546 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18378546 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.18361334 |
| 85 | Ulnar deviation of the wrist (HP:0003049) | 2.18197882 |
| 86 | Obstructive lung disease (HP:0006536) | 2.17934516 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17934516 |
| 88 | Increased IgM level (HP:0003496) | 2.17807344 |
| 89 | Hypolipoproteinemia (HP:0010981) | 2.16617718 |
| 90 | Recurrent skin infections (HP:0001581) | 2.16200631 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.15893930 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.15648317 |
| 93 | Ketosis (HP:0001946) | 2.15221486 |
| 94 | Recurrent viral infections (HP:0004429) | 2.14325733 |
| 95 | Hyperglycinuria (HP:0003108) | 2.13007457 |
| 96 | Abnormality of complement system (HP:0005339) | 2.12802884 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12750323 |
| 98 | Myopathic facies (HP:0002058) | 2.12454256 |
| 99 | Difficulty running (HP:0009046) | 2.12432403 |
| 100 | Gonadotropin excess (HP:0000837) | 2.11908108 |
| 101 | Biliary tract neoplasm (HP:0100574) | 2.10988020 |
| 102 | Late onset (HP:0003584) | 2.09695581 |
| 103 | Glomerulonephritis (HP:0000099) | 2.08993525 |
| 104 | Joint swelling (HP:0001386) | 2.08025587 |
| 105 | Gingivitis (HP:0000230) | 2.07749316 |
| 106 | Leukocytosis (HP:0001974) | 2.07570248 |
| 107 | Hypoalphalipoproteinemia (HP:0003233) | 2.06049228 |
| 108 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05554277 |
| 109 | Pulmonary embolism (HP:0002204) | 2.03896735 |
| 110 | Back pain (HP:0003418) | 2.03640902 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 2.03066302 |
| 112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.01524167 |
| 113 | Gangrene (HP:0100758) | 2.01326701 |
| 114 | Male infertility (HP:0003251) | 2.00829835 |
| 115 | Epidermoid cyst (HP:0200040) | 2.00110153 |
| 116 | Seborrheic dermatitis (HP:0001051) | 1.98847901 |
| 117 | Bundle branch block (HP:0011710) | 1.98193816 |
| 118 | Sudden death (HP:0001699) | 1.97936244 |
| 119 | Astrocytoma (HP:0009592) | 1.97233037 |
| 120 | Abnormality of the astrocytes (HP:0100707) | 1.97233037 |
| 121 | Basal cell carcinoma (HP:0002671) | 1.96357370 |
| 122 | Skin rash (HP:0000988) | 1.95898705 |
| 123 | Urticaria (HP:0001025) | 1.95224252 |
| 124 | Severe combined immunodeficiency (HP:0004430) | 1.94282266 |
| 125 | Amyloidosis (HP:0011034) | 1.91932321 |
| 126 | Hemoptysis (HP:0002105) | 1.91422761 |
| 127 | Right ventricular cardiomyopathy (HP:0011663) | 1.91299767 |
| 128 | Insulin resistance (HP:0000855) | 1.91211049 |
| 129 | Papilloma (HP:0012740) | 1.90988611 |
| 130 | Verrucae (HP:0200043) | 1.90988611 |
| 131 | Limb hypertonia (HP:0002509) | 1.90300959 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.90133763 |
| 133 | Neoplasm of striated muscle (HP:0009728) | 1.89796155 |
| 134 | Esophageal varix (HP:0002040) | 1.89737159 |
| 135 | Hyperacusis (HP:0010780) | 1.88840676 |
| 136 | Abnormality of the calcaneus (HP:0008364) | 1.88355085 |
| 137 | Sandal gap (HP:0001852) | 1.86794785 |
| 138 | Abnormality of purine metabolism (HP:0004352) | 1.86547968 |
| 139 | Muscle stiffness (HP:0003552) | 1.85864761 |
| 140 | Abnormal platelet volume (HP:0011876) | 1.85194588 |
| 141 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84529364 |
| 142 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84529364 |
| 143 | Cerebral palsy (HP:0100021) | 1.84116069 |
| 144 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83662177 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82863068 |
| 146 | Lymphangioma (HP:0100764) | 1.82341272 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.81468574 |
| 148 | Increased serum ferritin (HP:0003281) | 1.80696722 |
| 149 | Thrombocytosis (HP:0001894) | 1.80265981 |
| 150 | Acne (HP:0001061) | 1.80257681 |
| 151 | High pitched voice (HP:0001620) | 1.79265643 |
| 152 | Deviation of the thumb (HP:0009603) | 1.79118634 |
| 153 | Slow saccadic eye movements (HP:0000514) | 1.78833595 |
| 154 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78795638 |
| 155 | Abnormality of glycine metabolism (HP:0010895) | 1.78795638 |
| 156 | Heterotopia (HP:0002282) | 1.77997669 |
| 157 | Adenoma sebaceum (HP:0009720) | 1.77658733 |
| 158 | Angiofibromas (HP:0010615) | 1.77658733 |
| 159 | Abnormality of iron homeostasis (HP:0011031) | 1.77629033 |
| 160 | Eosinophilia (HP:0001880) | 1.77418094 |
| 161 | Volvulus (HP:0002580) | 1.77188967 |
| 162 | Facial hemangioma (HP:0000329) | 1.76857566 |
| 163 | Proximal placement of thumb (HP:0009623) | 1.75756029 |
| 164 | Increased nuchal translucency (HP:0010880) | 1.74976434 |
| 165 | Cerebral aneurysm (HP:0004944) | 1.74347290 |
| 166 | Ketoacidosis (HP:0001993) | 1.73863029 |
| 167 | Metaphyseal cupping (HP:0003021) | 1.73183751 |
| 168 | Cortical dysplasia (HP:0002539) | 1.72031048 |
| 169 | Aneurysm (HP:0002617) | 1.70858003 |
| 170 | Panhypogammaglobulinemia (HP:0003139) | 1.70620837 |
| 171 | Gout (HP:0001997) | 1.69407364 |
| 172 | Premature ovarian failure (HP:0008209) | 1.67452481 |
| 173 | Malnutrition (HP:0004395) | 1.67213386 |
| 174 | Overlapping toe (HP:0001845) | 1.65732969 |
| 175 | Neoplasm of the oral cavity (HP:0100649) | 1.65018449 |
| 176 | Amaurosis fugax (HP:0100576) | 1.64514922 |
| 177 | Hyperglycemia (HP:0003074) | 1.63671839 |
| 178 | Broad palm (HP:0001169) | 1.63202605 |
| 179 | Medulloblastoma (HP:0002885) | 1.63137760 |
| 180 | Ovarian neoplasm (HP:0100615) | 1.61300314 |
| 181 | Abnormal biliary tract morphology (HP:0012440) | 1.61181806 |
| 182 | Rhabdomyolysis (HP:0003201) | 1.60813832 |
| 183 | Thrombophlebitis (HP:0004418) | 1.60665768 |
| 184 | Abnormality of methionine metabolism (HP:0010901) | 1.60068809 |
| 185 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.59091497 |
| 186 | Granulocytopenia (HP:0001913) | 1.59061486 |
| 187 | Myocardial infarction (HP:0001658) | 1.57678018 |
| 188 | Thyroiditis (HP:0100646) | 1.57003136 |
| 189 | Hepatocellular carcinoma (HP:0001402) | 1.56710232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.94413993 |
| 2 | PRPF4B | 4.45686188 |
| 3 | PKN2 | 4.01228494 |
| 4 | TRIB3 | 3.81092949 |
| 5 | RIPK4 | 3.39083928 |
| 6 | CDK12 | 3.05140994 |
| 7 | CDC7 | 2.88166825 |
| 8 | NEK2 | 2.32657248 |
| 9 | STK10 | 2.28583277 |
| 10 | MAP3K10 | 2.24823162 |
| 11 | MAP3K13 | 2.22378129 |
| 12 | RPS6KB2 | 2.19070372 |
| 13 | MAP3K14 | 2.17534540 |
| 14 | JAK1 | 2.07162152 |
| 15 | OBSCN | 1.97146067 |
| 16 | TTK | 1.86613920 |
| 17 | NEK1 | 1.84664554 |
| 18 | ERN1 | 1.77849600 |
| 19 | PTK6 | 1.75515578 |
| 20 | CDK4 | 1.72577506 |
| 21 | TAOK3 | 1.71936050 |
| 22 | FES | 1.67953870 |
| 23 | FLT3 | 1.67616471 |
| 24 | MAP4K1 | 1.63697646 |
| 25 | BLK | 1.60415276 |
| 26 | MAPKAPK3 | 1.54305817 |
| 27 | CDK6 | 1.53545457 |
| 28 | LATS1 | 1.53206484 |
| 29 | PASK | 1.51716568 |
| 30 | SCYL2 | 1.51456946 |
| 31 | TAOK2 | 1.50894242 |
| 32 | LRRK2 | 1.43838345 |
| 33 | GRK6 | 1.40993998 |
| 34 | FGFR4 | 1.35457828 |
| 35 | MAP3K8 | 1.34026573 |
| 36 | IRAK4 | 1.32865344 |
| 37 | SYK | 1.30025626 |
| 38 | TBK1 | 1.25737305 |
| 39 | CDK7 | 1.22568767 |
| 40 | MAP3K6 | 1.22275555 |
| 41 | BCKDK | 1.21120862 |
| 42 | KIT | 1.17012602 |
| 43 | WEE1 | 1.17005209 |
| 44 | MAPK12 | 1.15080348 |
| 45 | EPHA3 | 1.12385047 |
| 46 | ZAP70 | 1.11501840 |
| 47 | MAP3K1 | 1.10543401 |
| 48 | IKBKE | 1.09078764 |
| 49 | SMG1 | 1.07767453 |
| 50 | ICK | 1.05753340 |
| 51 | TEC | 1.05041629 |
| 52 | TSSK6 | 1.04839649 |
| 53 | MAPK11 | 1.04332480 |
| 54 | KSR2 | 1.04021216 |
| 55 | PAK4 | 1.01914949 |
| 56 | MTOR | 1.01471337 |
| 57 | MAP2K3 | 1.00155576 |
| 58 | TTN | 0.98984479 |
| 59 | PDGFRA | 0.97301080 |
| 60 | ALK | 0.96259242 |
| 61 | JAK3 | 0.93450946 |
| 62 | CLK1 | 0.92501573 |
| 63 | STK3 | 0.92323940 |
| 64 | SIK1 | 0.88267444 |
| 65 | PIM1 | 0.87716216 |
| 66 | CDK9 | 0.85916718 |
| 67 | AURKB | 0.85303488 |
| 68 | CDC42BPA | 0.84955570 |
| 69 | PDK1 | 0.84664512 |
| 70 | IRAK1 | 0.84000418 |
| 71 | MAP3K7 | 0.83162010 |
| 72 | TYK2 | 0.83090187 |
| 73 | PRKAA2 | 0.82806328 |
| 74 | JAK2 | 0.82773754 |
| 75 | ATR | 0.82750535 |
| 76 | MELK | 0.82042257 |
| 77 | MAPK7 | 0.81909505 |
| 78 | ITK | 0.81717348 |
| 79 | TGFBR1 | 0.81402413 |
| 80 | MOS | 0.77969248 |
| 81 | PLK1 | 0.76660409 |
| 82 | FRK | 0.75097612 |
| 83 | DMPK | 0.74803416 |
| 84 | CHEK1 | 0.74565178 |
| 85 | TAOK1 | 0.73694438 |
| 86 | FGFR3 | 0.73170870 |
| 87 | CSK | 0.72748194 |
| 88 | IKBKB | 0.70059817 |
| 89 | LYN | 0.68828978 |
| 90 | RIPK1 | 0.67957484 |
| 91 | RET | 0.66327705 |
| 92 | PDGFRB | 0.65503871 |
| 93 | PDPK1 | 0.65396437 |
| 94 | BMPR2 | 0.63666170 |
| 95 | EPHA2 | 0.62572209 |
| 96 | BUB1 | 0.61961317 |
| 97 | STK4 | 0.61555274 |
| 98 | TESK2 | 0.60889802 |
| 99 | ATM | 0.60743780 |
| 100 | CHEK2 | 0.59021104 |
| 101 | MAP2K2 | 0.59004738 |
| 102 | RPS6KA4 | 0.58893590 |
| 103 | BRD4 | 0.58161990 |
| 104 | SGK3 | 0.57707509 |
| 105 | CDK2 | 0.56752855 |
| 106 | HIPK2 | 0.56744526 |
| 107 | MAP3K5 | 0.55939642 |
| 108 | WNK1 | 0.53790887 |
| 109 | PAK2 | 0.53515288 |
| 110 | MARK2 | 0.51570904 |
| 111 | TYRO3 | 0.51481196 |
| 112 | RAF1 | 0.50782195 |
| 113 | TXK | 0.50581844 |
| 114 | TGFBR2 | 0.48639222 |
| 115 | BRSK2 | 0.48613373 |
| 116 | MAPK3 | 0.47581516 |
| 117 | BTK | 0.47038134 |
| 118 | EPHB1 | 0.46260050 |
| 119 | YES1 | 0.46008602 |
| 120 | MAPK4 | 0.44959662 |
| 121 | MAPKAPK2 | 0.44456021 |
| 122 | PIK3CG | 0.44336069 |
| 123 | RPS6KC1 | 0.44000388 |
| 124 | RPS6KL1 | 0.44000388 |
| 125 | BMX | 0.43870593 |
| 126 | TNK2 | 0.43478277 |
| 127 | PDK2 | 0.43429139 |
| 128 | ERBB4 | 0.42746074 |
| 129 | FGR | 0.42093650 |
| 130 | IRAK3 | 0.41773270 |
| 131 | NLK | 0.38912625 |
| 132 | CSF1R | 0.38786852 |
| 133 | CAMK1G | 0.38221730 |
| 134 | MARK3 | 0.37909216 |
| 135 | CAMK1D | 0.37868010 |
| 136 | NEK9 | 0.36230856 |
| 137 | LATS2 | 0.34293018 |
| 138 | RPS6KA1 | 0.33513981 |
| 139 | CDK1 | 0.33059643 |
| 140 | TRPM7 | 0.30043706 |
| 141 | AKT2 | 0.29938654 |
| 142 | HCK | 0.29334291 |
| 143 | CSNK1D | 0.28887066 |
| 144 | LCK | 0.28797484 |
| 145 | MAP3K3 | 0.28276772 |
| 146 | AURKA | 0.27872218 |
| 147 | ACVR1B | 0.27787611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.83298032 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46980688 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.46410286 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.45000863 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38325339 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26803052 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19339962 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18611149 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14800946 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.09686989 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.91343639 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.91183580 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87864750 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87556419 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85876502 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.81940816 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76944234 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72940781 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.68775321 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.66370374 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.66212615 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.65249751 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61504964 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60439549 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60348986 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59462196 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58905741 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.58304704 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55596451 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.54328102 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52728344 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50131907 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48822149 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48564879 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48524969 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47178605 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45742485 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43987765 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42454421 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41949649 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.41428736 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40732956 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.37503614 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.33854415 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33598698 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.29033096 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28147631 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26943707 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24031952 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23405468 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22149122 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19745939 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18242067 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17589438 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15064022 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 1.13880723 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13694000 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.13205907 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13083096 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13066319 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07751841 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.07695951 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06648767 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.05839159 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05668331 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 1.04340603 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 1.04024104 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02715349 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02303027 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 1.00494523 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00348104 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99256348 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97672644 |
| 74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.96283557 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95339956 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90786257 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89335645 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88723077 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88047145 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87607279 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87287006 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86927946 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85552422 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84094957 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83814638 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83638371 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83104396 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82745059 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81593628 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80681020 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.78571926 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77695650 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.77137676 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76953746 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76632876 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.76625140 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.76473473 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75577505 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75238066 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.74149388 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73364886 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.73118443 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72120334 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71376384 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.71228085 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70333923 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67415021 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67237471 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67197029 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66639194 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64848791 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.64737617 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.64702380 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.63671580 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63476178 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63206135 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63048548 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62784795 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62766609 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62400190 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61704876 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61260435 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60309017 |
| 124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60070620 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58529626 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58433814 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56950088 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.56434020 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56277013 |
| 130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53309139 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53120899 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.51948000 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51830331 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51813196 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51490247 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51204601 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50010360 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49483763 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49249713 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.48979972 |
| 141 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48234716 |
| 142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47024406 |
| 143 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46822119 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45885538 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45021777 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.44591254 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44421609 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43438194 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41610401 |
| 150 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41344641 |
| 151 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41185337 |
| 152 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41167017 |
| 153 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41098764 |
| 154 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40976745 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39731261 |
| 156 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39118565 |
| 157 | Hepatitis B_Homo sapiens_hsa05161 | 0.38871060 |
| 158 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38419683 |

